Genetic Newborn Screening for Cystinosis and Primary Hyperoxaluria

Plain-language summary

This study evaluates genetic newborn screening for the early detection of two inherited diseases, cystinosis and primary hyperoxaluria. It enrolls newborns whose parents have consented to the screening. It is a study without an assigned phase and is currently recruiting.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Recruiting

Sponsor

Cystinose Stiftung

Intervention

Diagnostic test

Start date

3/15/2022

Estimated completion

6/30/2026

Countries

Germany

Related genes

Locations

• Hanover, Germany

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Newborns participating at the NGS with parent's consent to participate in this screening project

Exclusion Criteria:

* Newborns without parent's consent to participate in this screening project.